Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Warren, New Jersey
- Most recent report
- 10-Q, filed Aug 11, 2026
- Incorporated
- Delaware
- Filings on record
- 668 filings
- On EDGAR
- CIK 1398733
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 33
News 8 of 176
- 8-K Quarterly results Aug 11, 2026
- 8-K Other events Aug 10, 2026
- 8-K Shareholder vote results Jun 10, 2026
- 8-K Quarterly results May 13, 2026
- 8-K Current report on a material event Mar 30, 2026
- 8-K Leadership change Mar 20, 2026
- 8-K Quarterly results Mar 4, 2026
- 8-K Current report on a material event Feb 26, 2026
Prospectuses and Registrations 8 of 42
- 424B3 Prospectus supplement for an offering Jul 9, 2026
- S-3 Shelf registration statement Jun 26, 2026
- S-8 Registration statement for an employee plan Mar 4, 2026
- S-8 Registration statement for an employee plan Jan 21, 2026
- 424B5 Prospectus supplement for an offering Aug 14, 2025
- S-8 Registration statement for an employee plan Jan 24, 2025
- 424B2 Prospectus supplement for an offering Apr 24, 2024
- 424B2 Prospectus supplement for an offering Apr 24, 2024
Proxies 8 of 19
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
Ownership 8 of 352
- 144 Notice of a proposed sale of restricted stock Sep 9, 2026
- 4 Insider reported a trade Sep 9, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 17, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 27, 2026
- 4 Insider reported a trade Jul 17, 2026
Other 8 of 46
- EFFECT Notice that a registration became effective Jul 8, 2026
- ARS Annual report sent to shareholders Apr 24, 2026
- ARS Annual report sent to shareholders Apr 25, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- EFFECT Notice that a registration became effective Apr 23, 2024
- CORRESP Reply to SEC staff Apr 19, 2024
- CORRESP Reply to SEC staff Apr 19, 2024
- CORRESP Reply to SEC staff Apr 16, 2024
Everything here comes from Aquestive Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.